Cargando…

Clinical performance of primary HPV screening cut‐off for colposcopy referrals in HPV‐vaccinated cohort: Observational study

OBJECTIVE: To understand the effect of changing from cytology‐based to primary HPV screening on the positive predictive value (PPV) of colposcopy referrals for cervical intraepithelial neoplasia (CIN) in a cohort offered HPV vaccination. DESIGN: Retrospective pre/post observational cohort study. SET...

Descripción completa

Detalles Bibliográficos
Autores principales: Beecroft, Marikka, Gurumurthy, Mahalakshmi, Cruickshank, Margaret E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087227/
https://www.ncbi.nlm.nih.gov/pubmed/36054732
http://dx.doi.org/10.1111/1471-0528.17284
_version_ 1785022298872348672
author Beecroft, Marikka
Gurumurthy, Mahalakshmi
Cruickshank, Margaret E.
author_facet Beecroft, Marikka
Gurumurthy, Mahalakshmi
Cruickshank, Margaret E.
author_sort Beecroft, Marikka
collection PubMed
description OBJECTIVE: To understand the effect of changing from cytology‐based to primary HPV screening on the positive predictive value (PPV) of colposcopy referrals for cervical intraepithelial neoplasia (CIN) in a cohort offered HPV vaccination. DESIGN: Retrospective pre/post observational cohort study. SETTING: Scotland. POPULATION OR SAMPLE: 2193 women referred to colposcopy between September 2019 and February 2020 from cytology‐based screening and between September 2020 and February 2021 from primary high‐risk HPV (hrHPV) screening. METHODS: Calculating positive predictive values (PPVs) for two cohorts of women; one having liquid‐based cytology screening and the other, the subsequent hrHPV cervical screening as a pre/post observational study. MAIN OUTCOME MEASURES: Positive predictive values of LBC and hrHPV cut‐offs for colposcopy referral for CIN at colposcopy. RESULTS: Three papers fitted our criteria; these reported results only for cytology‐based screening. The PPV was lower for women in HPV‐vaccinated cohorts indicating a lower prevalence of disease. Vaccination under the age of 17 had the lowest PPV reported. Scottish colposcopy data concerning hrHPV and cytology showed a non‐significant difference between PPV (17.5%, 95% CI 14.3–20.7, and 20.6, 95% CI 16.7–24.5, respectively) for referrals with a cut‐off of low grade dyskaryosis (LGD); both met the standard set of 8–25%. The hrHPV PPV (66.7, 95% CI 56.8–76.6) was comparable to cytology (64.1, 95% CI 55.8–72.4) for referrals with a cut‐off of high grade dyskaryosis (HGD) but neither met the standard set of 77–92%. CONCLUSIONS: Current literature only provides PPVs for LBC and, overall, the vaccinated cohort had lower PPVs. Only LG dyskaryosis met PHE criteria. The PPV for HPV‐vaccinated women undergoing either LBC or HR‐HPV screening were not statistically different. However, similar to papers in the current literature, HG dyskaryosis (HGD) PPVs of both techniques did not meet the PHE threshold of 76.6–91.6% outlined in the cervical standards data report.
format Online
Article
Text
id pubmed-10087227
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-100872272023-04-12 Clinical performance of primary HPV screening cut‐off for colposcopy referrals in HPV‐vaccinated cohort: Observational study Beecroft, Marikka Gurumurthy, Mahalakshmi Cruickshank, Margaret E. BJOG RESEARCH ARTICLES OBJECTIVE: To understand the effect of changing from cytology‐based to primary HPV screening on the positive predictive value (PPV) of colposcopy referrals for cervical intraepithelial neoplasia (CIN) in a cohort offered HPV vaccination. DESIGN: Retrospective pre/post observational cohort study. SETTING: Scotland. POPULATION OR SAMPLE: 2193 women referred to colposcopy between September 2019 and February 2020 from cytology‐based screening and between September 2020 and February 2021 from primary high‐risk HPV (hrHPV) screening. METHODS: Calculating positive predictive values (PPVs) for two cohorts of women; one having liquid‐based cytology screening and the other, the subsequent hrHPV cervical screening as a pre/post observational study. MAIN OUTCOME MEASURES: Positive predictive values of LBC and hrHPV cut‐offs for colposcopy referral for CIN at colposcopy. RESULTS: Three papers fitted our criteria; these reported results only for cytology‐based screening. The PPV was lower for women in HPV‐vaccinated cohorts indicating a lower prevalence of disease. Vaccination under the age of 17 had the lowest PPV reported. Scottish colposcopy data concerning hrHPV and cytology showed a non‐significant difference between PPV (17.5%, 95% CI 14.3–20.7, and 20.6, 95% CI 16.7–24.5, respectively) for referrals with a cut‐off of low grade dyskaryosis (LGD); both met the standard set of 8–25%. The hrHPV PPV (66.7, 95% CI 56.8–76.6) was comparable to cytology (64.1, 95% CI 55.8–72.4) for referrals with a cut‐off of high grade dyskaryosis (HGD) but neither met the standard set of 77–92%. CONCLUSIONS: Current literature only provides PPVs for LBC and, overall, the vaccinated cohort had lower PPVs. Only LG dyskaryosis met PHE criteria. The PPV for HPV‐vaccinated women undergoing either LBC or HR‐HPV screening were not statistically different. However, similar to papers in the current literature, HG dyskaryosis (HGD) PPVs of both techniques did not meet the PHE threshold of 76.6–91.6% outlined in the cervical standards data report. John Wiley and Sons Inc. 2022-09-07 2023-01 /pmc/articles/PMC10087227/ /pubmed/36054732 http://dx.doi.org/10.1111/1471-0528.17284 Text en © 2022 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle RESEARCH ARTICLES
Beecroft, Marikka
Gurumurthy, Mahalakshmi
Cruickshank, Margaret E.
Clinical performance of primary HPV screening cut‐off for colposcopy referrals in HPV‐vaccinated cohort: Observational study
title Clinical performance of primary HPV screening cut‐off for colposcopy referrals in HPV‐vaccinated cohort: Observational study
title_full Clinical performance of primary HPV screening cut‐off for colposcopy referrals in HPV‐vaccinated cohort: Observational study
title_fullStr Clinical performance of primary HPV screening cut‐off for colposcopy referrals in HPV‐vaccinated cohort: Observational study
title_full_unstemmed Clinical performance of primary HPV screening cut‐off for colposcopy referrals in HPV‐vaccinated cohort: Observational study
title_short Clinical performance of primary HPV screening cut‐off for colposcopy referrals in HPV‐vaccinated cohort: Observational study
title_sort clinical performance of primary hpv screening cut‐off for colposcopy referrals in hpv‐vaccinated cohort: observational study
topic RESEARCH ARTICLES
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087227/
https://www.ncbi.nlm.nih.gov/pubmed/36054732
http://dx.doi.org/10.1111/1471-0528.17284
work_keys_str_mv AT beecroftmarikka clinicalperformanceofprimaryhpvscreeningcutoffforcolposcopyreferralsinhpvvaccinatedcohortobservationalstudy
AT gurumurthymahalakshmi clinicalperformanceofprimaryhpvscreeningcutoffforcolposcopyreferralsinhpvvaccinatedcohortobservationalstudy
AT cruickshankmargarete clinicalperformanceofprimaryhpvscreeningcutoffforcolposcopyreferralsinhpvvaccinatedcohortobservationalstudy